HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN

Invention Application

US20200165356A1 HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN 审中-公开

Patent Title: HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN
Application No.: US16375777

Application Date: 2019-04-04
Publication No.: US20200165356A1

Publication Date: 2020-05-28
Inventor: John Desjarlais , Alex Nisthal , Seung Chu
Applicant: Xencor, Inc.
Main IPC: C07K16/40
IPC: C07K16/40 ; C07K16/28 ; C07K16/46

Abstract:

The present invention relates to novel antigen binding domains and heterodimeric antibodies that bind Fibroblast Activation Protein (FAP).

Public/Granted literature

Information query

Global Dossier Espacenet

IPC分类:

C	化学；冶金
C07	有机化学
C07K	肽（含有β-内酰胺的肽入C07D；在分子中除了形成本身的肽环外不含有任何其他的肽键的环状二肽，如哌嗪-2,5-二酮入C07D；环肽型麦角生物碱入C07D519/02；单细胞蛋白质、酶入C12N；获得肽的基因工程方法入C12N15/00）
C07K16/00	免疫球蛋白，例如，单克隆或多克隆抗体
C07K16/40	.抗酶